4//SEC Filing
Birchall Jonathan 4
Accession 0001169245-22-000075
CIK 0001169245other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 5:13 PM ET
Size
5.2 KB
Accession
0001169245-22-000075
Insider Transaction Report
Form 4
Birchall Jonathan
Chief Commercial Officer
Transactions
- Award
Common Stock
2022-05-20$0.68/sh+20,000$13,626→ 20,000 total
Footnotes (2)
- [F1]Shares were acquired under the Issuer's Employee Stock Purchase Plan ("ESPP") in a transaction that is exempt under both Rule 16b-3(c) and Rule 16b-3(d).
- [F2]In accordance with the ESPP provisions, these shares were purchased based on 85% of the closing price of the Issuer's common stock on May 20, 2022.
Documents
Issuer
PhaseBio Pharmaceuticals Inc
CIK 0001169245
Entity typeother
Related Parties
1- filerCIK 0001892776
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 5:13 PM ET
- Size
- 5.2 KB